Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:05 pm Purchase |
2024-12-31 | 13G | Theravance Biopharma, Inc. TBPH |
Newtyn Management, LLC | 4,757,403 9.700% |
657,403 (+16.03%) |
Filing History |
| 2024-11-14 09:53 am Purchase |
2024-09-30 | 13G | Theravance Biopharma, Inc. TBPH |
Madison Avenue International LP | 9,511,150 19.400% |
999,800 (+11.75%) |
Filing History |
| 2024-11-12 5:53 pm Unchanged |
2024-09-30 | 13G | Theravance Biopharma, Inc. TBPH |
The Vanguard Group | 2,051,689 4.190% |
0 (Unchanged) |
Filing History |
| 2024-11-04 3:33 pm Unchanged |
2024-09-30 | 13G | Theravance Biopharma, Inc. TBPH |
The Vanguard Group | 2,051,689 4.190% |
0 (Unchanged) |
Filing History |
| 2024-11-04 2:10 pm Sale |
2024-09-30 | 13G | Theravance Biopharma, Inc. TBPH |
The Vanguard Group | 2,051,689 4.190% |
-1,437,573 (-41.20%) |
Filing History |
| 2024-10-24 4:44 pm Sale |
2024-09-30 | 13G | Theravance Biopharma, Inc. TBPH |
BLACKROCK INC BLK |
3,728,382 7.600% |
-856,214 (-18.68%) |
Filing |
| 2024-09-09 5:42 pm Sale |
2024-08-31 | 13G | Theravance Biopharma, Inc. TBPH |
BAUPOST GROUP LLC | 0 0.000% |
-2,977,304 (Position Closed) |
Filing History |
| 2024-08-16 4:05 pm Purchase |
2024-08-07 | 13G | Theravance Biopharma, Inc. TBPH |
Newtyn Management, LLC | 4,100,000 8.400% |
4,100,000 (New Position) |
Filing History |
| 2024-08-09 4:14 pm Sale |
2024-07-31 | 13G | Theravance Biopharma, Inc. TBPH |
BAUPOST GROUP LLC | 2,977,304 6.120% |
-4,441,922 (-59.87%) |
Filing History |
| 2024-06-11 4:17 pm Sale |
2024-05-10 | 13G | Theravance Biopharma, Inc. TBPH |
ODRE 2005 SLU | 0 0.000% |
-4,108,318 (Position Closed) |
Filing History |
| 2024-05-03 5:49 pm Purchase |
2024-05-01 | 13G | Theravance Biopharma, Inc. TBPH |
Madison Avenue International LP | 8,511,350 17.500% |
1,499,124 (+21.38%) |
Filing History |
| 2024-03-05 09:01 am Unchanged |
2024-03-01 | 13D | Theravance Biopharma, Inc. TBPH |
Weiss Asset Management LP | 7,457,060 15.500% |
0 (Unchanged) |
Filing History |
| 2024-02-14 4:00 pm Purchase |
2023-12-31 | 13G | Theravance Biopharma, Inc. TBPH |
Irenic Capital Management LP | 2,760,948 5.500% |
2,760,948 (New Position) |
Filing History |
| 2024-02-13 5:15 pm Sale |
2023-12-29 | 13G | Theravance Biopharma, Inc. TBPH |
The Vanguard Group | 3,489,262 7.010% |
-2,069,577 (-37.23%) |
Filing History |
| 2024-02-08 4:54 pm Sale |
2023-12-31 | 13G | Theravance Biopharma, Inc. TBPH |
BLACKROCK INC BLK |
4,584,596 9.200% |
-745,234 (-13.98%) |
Filing |
| 2023-08-14 5:05 pm Unchanged |
2023-08-09 | 13D | Theravance Biopharma, Inc. TBPH |
Weiss Asset Management LP | 7,457,060 14.120% |
0 (Unchanged) |
Filing History |
| 2023-07-10 4:33 pm Sale |
2023-06-30 | 13G | Theravance Biopharma, Inc. TBPH |
BAUPOST GROUP LLC | 7,419,226 12.840% |
-4,000,000 (-35.03%) |
Filing History |
| 2023-04-12 1:51 pm Unchanged |
2023-04-11 | 13D | Theravance Biopharma, Inc. TBPH |
Weiss Asset Management LP | 7,457,060 11.790% |
0 (Unchanged) |
Filing History |
| 2023-02-14 5:07 pm Sale |
2022-12-31 | 13G | Theravance Biopharma, Inc. TBPH |
ORBIMED ADVISORS LLC | 0 0.000% |
-5,456,780 (Position Closed) |
Filing History |
| 2023-02-14 09:58 am Purchase |
2022-12-31 | 13G | Theravance Biopharma, Inc. TBPH |
Madison Avenue International LP | 7,012,226 10.400% |
364,201 (+5.48%) |
Filing History |